Parathyroid hormone and bone biomechanics

Clinical Reviews in Bone and Mineral Metabolism

Volumn 4, Issue 4, 2006, Pages 259-268

  Allen, Matthew R ^a   Burr, David B ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Indiana University Purdue University Indianapolis   (United States)

^c MS 5035 ^*  (United States)

Author keywords

Bone geometry; Mechanical properties; Teriparatide; Trabecular architecture

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RECOMBINANT PARATHYROID HORMONE;

ARTICLE; BIOMECHANICS; BONE; BONE DENSITY; BONE MASS; BONE MINERALIZATION; BONE STRUCTURE; BONE THICKNESS; CORTICAL BONE; DISEASE PREDISPOSITION; FRACTURE; HUMAN; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOPOROSIS; TRABECULAR BONE;

EID: 34147113833     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:4:4:259     Document Type: Article

References (52)

1. Burr DB, Turner CH. 2003 Biomechanics of bone. In: Favus M (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. American Society for Bone and Mineral Research, Washington DC, pp 58-64.
2. Turner CH, Burr DB. 1993 Basic biomechanical measurements of bone: a tutorial. Bone 14:595-608.
3. Currey JD. 2004 Tensile yield in compact bone is determined by strain, post-yield behavior by mineral content. J Biomech 37:549-56.
4. Black DM, Greenspan SL, Ensrud KE et al. 2003 The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207-1215.
5. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. 2003 The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216-1226.
6. Dempster DW, Cosman F, Kurland ES et al. 2001 Effects of daily treatment with parathyroid hormone on bone micro-architecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846-1853.
7. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. 2003 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932-1941.
8. Arlot M, Meunier PJ, Boivin G et al. 2005 Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res 20:1244-1253.
9. Burr D, Hirano T, Turner C, Hotchkiss C, Brommage R, Hock J. 2001 Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16:157-165.
10. Sato M, Westmore M, Ma YL et al. 2004 Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res 19:623-629.
11. Hirano T, Burr DB, Cain RL, Hock JM. 2000 Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34). Calcif Tissue Int 66:456-460.
12. Mashiba T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM. 2001 Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. Bone 28:538-547.
13. Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM. 1999 Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536-545.
14. Jerome CP, Johnson CS, Vafai HT et al. 1999 Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 25:301-309.
15. Uusi-Rasi K, Semanick LM, Zanchetta JR et al. 2005 Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948-958.
16. Zanchetta JR, Bogado CE, Ferretti JL et al. 2003 Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539-543.
17. Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH. 2000 Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis. Bone 27:311-318.
18. 3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11:600-613.
19. Martin RB, Burr DB, Sharkey NA. 1998 Skeletal Tissue Mechanics. Springer, New York.
20. Pead MJ, Skerry TM, Lanyon LE. 1988 Direct transformation from quiescence to bone formation in the adult periosteum following a single brief period of bone loading. J Bone Miner Res 3:647-656.
21. Hodsman AB, Steer BM. 1993 Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces. Bone 14:523-527.
22. Dobnig H, Turner RT. 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638.
23. Burr DB. 2005 Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size. Curr Osteoporos Rep 3:19-24.
24. van der Linden JC, Homminga J, Verhaar JA, Weinans H. 2001 Mechanical consequences of bone loss in cancellous bone. J Bone Miner Res 16:457-465.
25. Frost HM. 2004 The Utah Paradigm of Skeletal Physiology, vol. I. International Society of Musculoskeletal and Neuronal Interactions, Greece.
26. Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R. 2001 Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150-159.
27. Ulrich D, van Rietbergen B, Laib A, Ruegsegger P. 1999 The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25:55-60.
28. Guo XE, Kim CH. 2002 Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone 30:404-411.
29. Pistoia W, van Rietbergen B, Ruegsegger P. 2003 Mechanical consequences of different scenarios for simulated bone atrophy and recovery in the distal radius. Bone 33:937-945.
30. Sato M, Westmore M, Clendenon J et al. 2000 Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques. Osteoporos Int 11:871-880.
31. Zhang L, Takahashi HE, Inoue J et al. 1997 Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501-506.
32. Kinney JH, Ladd AJ. 1998 The relationship between three-dimensional connectivity and the elastic properties of trabecular bone. J Bone Miner Res 13:839-845.
33. Goldstein SA, Goulet R, McCubbrey D. 1993 Measurement and significance of three-dimensional architecture to the mechanical integrity of trabecular bone. Calcif Tissue Int 53(Suppl 1):S127-S132; discussion S132-S133.
34. Kabel J, Odgaard A, van Rietbergen B, Huiskes R. 1999 Connectivity and the elastic properties of cancellous bone. Bone 24:115-120.
35. Compston JE. 1994 Connectivity of cancellous bone: assessment and mechanical implications. Bone 15:463-466.
36. Keaveny TM. 2001 Strength of trabecular bone. In: Cowin S (ed.) Bone mechanics handbook, Second ed. CRC Press, Boca Raton.
37. Miller Z, Fuchs MB. 2005 Effect of trabecular curvature on the stiffness of trabecular bone. J Biomech 38:1855-1864.
38. Meng XW, Liang XG, Birchman R et al. 1996 Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res 11:421-429.
39. Paschalis EP, Burr DB, Mendelsohn R, Hock JM, Boskey AL. 2003 Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months. J Bone Miner Res 18:769-775.
40. Misof BM, Roschger P, Cosman F et al. 2003 Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150-1156.
41. Burr DB, Schaffler MB, Frederickson RG. 1988 Composition of the cement line and its possible mechanical role as a local interface in human compact bone. J Biomech 21:939-945.
42. Vashishth D, Tanner KE, Bonfield W. 2003 Experimental validation of a microcracking-based toughening mechanism for cortical bone. J Biomech 36:121-124.
43. O'Brien FJ, Taylor D, Lee TC. 2003 Microcrack accumulation at different intervals during fatigue testing of compact bone. J Biomech 36:973-980.
44. Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM. 2000 Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893. J Bone Miner Res 15:1517-1525.
45. Ejersted C, Andreassen TT, Hauge EM, Melsen F, Oxlund H. 1995 Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone 17:507-511.
46. Sato M, Zeng GQ, Turner CH. 1997 Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology 138:4330-4337.
47. Sato M, Vahle J, Schmidt A et al. 2002 Abnormal bone architecture and biomechanical properties with near-life-time treatment of rats with PTH. Endocrinology 143:3230-3242.
48. Currey JD. 2002 Bones: Structure and Mechanics. Princeton University Press, Princeton.
49. Marotti G, Favia A, Zallone AZ. 1972 Quantitative analysis on the rate of secondary bone mineralization. Calcif Tissue Res 10:67-81.
50. Fuchs R, Allen M, Ruppel M, Miler L, Burr D. 2005 How long does secondary mineralization of osteonal bone take? J Bone Miner Res 20(Supp 1):M047.
51. van der Linden JC, Birkenhager-Frenkel DH, Verhaar JA, Weinans H. 2001 Trabecular bone's mechanical properties are affected by its non-uniform mineral distribution. J Biomech 34:1573-1580.
52. Black DM, Bilezikian JP, Ensrud KE et al. 2005 One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 353:555-565.